Stockscreener 앱 받기
16.79
3.07%
0.48
전일 마감가:
$16.31
열려 있는:
$16.31
하루 거래량:
578.88K
Relative Volume:
0.23
시가총액:
$2.13B
수익:
$631.73M
순이익/손실:
$-239.78M
주가수익비율:
-8.3119
EPS:
-2.02
순현금흐름:
$-33.45M
1주 성능:
+1.94%
1개월 성능:
-6.30%
6개월 성능:
+29.21%
1년 성능:
+18.46%
1일 변동 폭
$16.23
$17.17
1주일 범위
$15.91
$17.17
52주 변동 폭
$6.78
$20.34
10X 제노믹스 Stock (TXG) Company Profile
명칭
10 X Genomics Inc
전화
(925) 401-7300
주소
6230 STONERIDGE MALL ROAD, PLEASANTON, CA
TXG을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TXG
10 X Genomics Inc
|
16.81 | 2.06B | 631.73M | -239.78M | -33.45M | -2.02 |
|
VEEV
Veeva Systems Inc
|
220.16 | 36.69B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
61.48 | 10.51B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
43.60 | 8.34B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
91.82 | 7.83B | 1.15B | 96.70M | -161.99M | 1.09 |
|
BTSG
Brightspring Health Services Inc
|
38.14 | 6.75B | 11.99B | 24.18M | 234.31M | 0.2956 |
10X 제노믹스 Stock (TXG) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-11 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2025-12-02 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2025-09-11 | 개시 | Piper Sandler | Neutral |
| 2025-02-13 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2024-09-03 | 개시 | Leerink Partners | Outperform |
| 2024-07-22 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-07-18 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-07-10 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2024-06-27 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2024-06-25 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2024-06-03 | 재개 | Jefferies | Hold |
| 2024-05-01 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2023-12-14 | 개시 | Guggenheim | Buy |
| 2023-12-13 | 개시 | Wolfe Research | Outperform |
| 2023-12-12 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2023-07-05 | 재개 | JP Morgan | Overweight |
| 2023-05-10 | 개시 | Barclays | Overweight |
| 2023-03-31 | 개시 | Stephens | Overweight |
| 2023-02-02 | 개시 | UBS | Neutral |
| 2022-12-14 | 개시 | Deutsche Bank | Buy |
| 2022-08-18 | 다운그레이드 | Goldman | Neutral → Sell |
| 2022-07-25 | 개시 | Canaccord Genuity | Buy |
| 2022-07-15 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2022-07-15 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-09-14 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2021-03-15 | 개시 | William Blair | Outperform |
| 2020-12-02 | 개시 | Goldman | Neutral |
| 2020-09-09 | 개시 | Morgan Stanley | Overweight |
| 2020-07-10 | 개시 | Stifel | Buy |
| 2020-03-05 | 개시 | Guggenheim | Buy |
| 2020-01-07 | 개시 | Citigroup | Buy |
| 2019-10-07 | 개시 | BofA/Merrill | Buy |
| 2019-10-07 | 개시 | Cowen | Outperform |
| 2019-10-07 | 개시 | JP Morgan | Overweight |
| 2019-09-24 | 개시 | Evercore ISI | Outperform |
모두보기
10X 제노믹스 주식(TXG)의 최신 뉴스
Financial Consulate Inc. Acquires New Holdings in 10x Genomics $TXG - MarketBeat
Weekly Earnings: Is 10x Genomics Inc 1KJ stock a top pick for value investorsWeekly Investment Report & Low Drawdown Trading Strategies - moha.gov.vn
S P Trends: How dovish Fed policy supports 10x Genomics Inc 1KJ stockMarket Sentiment Review & Weekly Watchlist of Top Performers - moha.gov.vn
10x Genomics to Present at the 44th Annual J.P. Morgan Healthcare Conference - Barchart.com
10x Genomics' Products Are Well-Received, But US Spending Weakness Stifles Growth (NASDAQ:TXG) - Seeking Alpha
Osaic Holdings Inc. Has $1.89 Million Stock Position in 10x Genomics $TXG - MarketBeat
Assenagon Asset Management S.A. Sells 1,696,984 Shares of 10x Genomics $TXG - MarketBeat
Friedenthal Financial Purchases New Holdings in 10x Genomics $TXG - MarketBeat
10x Genomics (NASDAQ:TXG) Trading Down 4.1%Should You Sell? - MarketBeat
Barclays Turns More Bullish on 10x Genomics, Inc. (TXG) Despite Uneven Research Spending - Finviz
Barclays turns more bullish on 10x Genomics, Inc. (TXG) despite uneven research spending - MSN
Canaccord Genuity Maintains 10x Genomics (TXG) Buy Recommendation - Nasdaq
10x Genomics (TXG) Stock Trades Up, Here Is Why - Finviz
10x Genomics (TXG) Maintains Buy Rating, Price Target Raised to $20 | TXG Stock News - GuruFocus
10x Genomics (NASDAQ:TXG) Given New $20.00 Price Target at Canaccord Genuity Group - MarketBeat
Why 10x Genomics Inc. stock could outperform in 20252025 Price Targets & Fast Entry Momentum Trade Alerts - Улправда
How 10x Genomics Inc. stock responds to policy changesWall Street Watch & Weekly High Conviction Trade Ideas - ulpravda.ru
Aug Swings: Can 10x Genomics Inc. (1KJ) stock sustain breakout momentumQuarterly Trade Summary & AI Driven Stock Movement Reports - Улправда
Price Action: Is 10x Genomics Inc. stock safe for conservative investorsJuly 2025 Opening Moves & Weekly Breakout Watchlists - Улправда
Is 10x Genomics Inc. stock safe for conservative investorsJuly 2025 Decliners & Consistent Income Trade Ideas - Улправда
Is 10x Genomics Inc. (1KJ) stock attractive for growth fundsJuly 2025 Movers & Free High Accuracy Swing Entry Alerts - Улправда
Can 10x Genomics Inc. (1KJ) stock sustain breakout momentumJuly 2025 Closing Moves & Weekly High Return Stock Opportunities - Улправда
What technical charts say about 10x Genomics Inc. stockJuly 2025 Summary & Free Real-Time Volume Trigger Notifications - DonanımHaber
Panic Selling: How 10x Genomics Inc. stock responds to policy changesJuly 2025 PreEarnings & Low Risk High Win Rate Picks - Улправда
Lancaster Investment Management Purchases Shares of 621,779 10x Genomics $TXG - MarketBeat
How 10x Genomics Inc. stock benefits from strong dollarWeekly Stock Summary & Comprehensive Market Scan Insights - DonanımHaber
Is 10x Genomics Inc. stock oversold or undervaluedJuly 2025 Recap & Daily Oversold Bounce Ideas - DonanımHaber
Why 10x Genomics Inc. stock could benefit from AI revolutionEntry Point & Short-Term Trading Alerts - Улправда
Is 10x Genomics Inc. stock a safe haven assetQuarterly Performance Summary & Technical Confirmation Alerts - DonanımHaber
History Review: Why 10x Genomics Inc. stock could outperform in 2025 - Улправда
Aug Rallies: Can 10x Genomics Inc. stock weather global recession2025 Winners & Losers & Low Risk High Reward Ideas - Улправда
Can 10x Genomics Inc. stock weather global recessionMarket Activity Report & Growth Focused Investment Plans - Улправда
Bear Alert: Why 10x Genomics Inc. stock could benefit from AI revolutionQuarterly Earnings Summary & Weekly Chart Analysis and Guides - Улправда
Setup Watch: Is 10x Genomics Inc. stock safe for conservative investors2025 Major Catalysts & Weekly Top Gainers Trade List - Улправда
Market Fear: How 10x Genomics Inc. stock responds to policy changesShare Buyback & Low Risk Growth Stock Ideas - Улправда
Barclays Maintains 10x Genomics (TXG) Overweight Recommendation - Nasdaq
Caxton Associates LLP Sells 259,388 Shares of 10x Genomics $TXG - MarketBeat
10x Genomics (NASDAQ:TXG) Given Average Recommendation of "Hold" by Analysts - MarketBeat
10x Genomics $TXG Position Increased by Nikko Asset Management Americas Inc. - MarketBeat
Why The Narrative Around 10x Genomics Is Shifting After New Institutional Buying And Product Updates - Yahoo Finance
Bellevue Group AG Buys 95,754 Shares of 10x Genomics $TXG - MarketBeat
Federated Hermes Inc. Has $9.12 Million Holdings in 10x Genomics $TXG - MarketBeat
Why 10x Genomics (TXG) stock is nosediving - MSN
TXG: Citigroup Downgrades 10x Genomics to Neutral with $18 Price Target | TXG Stock News - GuruFocus
10x Genomics (TXG) Q2 2025 Earnings Transcript - The Motley Fool
10x Genomics (TXG) Stock: Citi Downgrade, AI Partnerships and 2026 Forecast After December 11 Sell-Off - ts2.tech
Why 10x Genomics (TXG) Stock Is Nosediving - Finviz
10x Genomics' (TXG) Neutral Rating Reaffirmed at Citigroup - MarketBeat
Citigroup Downgrades 10x Genomics to Neutral From Buy, Price Target is $18 - marketscreener.com
Blue Water Life Science Advisors LP Buys New Holdings in 10x Genomics $TXG - MarketBeat
10x Genomics $TXG Shares Bought by Jump Financial LLC - MarketBeat
10X 제노믹스 (TXG) 재무 분석
매출
순이익
현금흐름
주당 순 이익
10X 제노믹스 주식 (TXG) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Hindson Benjamin J. | See Remarks |
Nov 24 '25 |
Sale |
19.00 |
8,283 |
157,363 |
432,605 |
| Saxonov Serge | Chief Executive Officer |
Nov 24 '25 |
Sale |
19.00 |
13,261 |
251,936 |
1,021,556 |
0.24%
0.89%
자본화:
|
볼륨(24시간):